tirzepatide pipeline Biomed Industries Advances NA-931 Into Two Global Phase 3 Trials Alone and with Semaglutide and for Obesity Zepbound Prefilled Syringe (Tirzepatide) 7.5mg/.5ml
Description
Cravings should be few and far between by then as well
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (marketed as Mounjaro) and chronic weight management (marketed as Zepbound)
Zepbound (tirzepatide) is a twincretin (i.e., GIP RA and GLP-1 RA)
You should not be at this dose unless you have already completed at least two months on lower doses and your provider has approved the increase
